PDLI
PDL BioPharma, Inc.
PDLI
PDLI
Delisted
PDLI was delisted on the 30th of December, 2020.
150 hedge funds and large institutions have $318M invested in PDL BioPharma, Inc. in 2019 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 33 increasing their positions, 63 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
48% less repeat investments, than reductions
Existing positions increased: 33 | Existing positions reduced: 63
Holders
150
Holding in Top 10
1
Calls
$459K
Puts
$150K
Top Buyers
| 1 | +$20.1M | |
| 2 | +$5.06M | |
| 3 | +$4.87M | |
| 4 |
AA
Ancora Advisors
Cleveland,
Ohio
|
+$4.26M |
| 5 |
CCM
Context Capital Management
Lajolla,
California
|
+$2.32M |
Top Sellers
| 1 | -$7.97M | |
| 2 | -$4.31M | |
| 3 | -$3.87M | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$3.85M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$2.33M |